Week 48 safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced participants (BRIGHTE study)
2018-01-01 Aberg, J; Molina, J; Kozal, M; Cahn, P; Lalezari, J; Thompson, M; Diaz, R; Castagna, A; Pialoux, G; Gummel, M; Pierce, A; Ackerman, P; Llamoso, C; Lataillade, M
THE EFFECT OF HIV-1 IN DECREASING MITOCHONDRIAL DNA IN PERIPHERAL BLOOD MONONUCLEAR CELLS OVERCOMES THE TOXIC EFFECT OF ANTIRETROVIRAL THERAPY (ART)
2009-01-01 Bossolasco, S; Danise, A; Galli, L; Bestetti, A; Galli, A; Lazzarin, A; Castagna, A; Cinque, P
FAILURE TO DARUNAVIR/RITONAVIR CAN EITHER INCREASE OR DECREASE TIPRANAVIR/RITONAVIR GENOTYPIC RESISTANCE SCORE IN HIGHLY TREATMENT-EXPERIENCED HIV-INFECTED PATIENTS
2009-01-01 Gianotti, N; Spagnuolo, V; Bigoloni, A; Vinci, C; Salpietro, S; Seminari, E; Lazzarin, A; Castagna, A
A RELATIVELY SLOW RISK OF DISEASE PROGRESSION IN HIV-POSITIVE PATIENTS WITH INDOLENT INFECTION HAS BEEN FOUND IN THE ICONA COHORT
2009-01-01 Ammassari, A; Cozzi-Lepri, A; De Luca, A; Girardi, E; Arlotti, M; Torti, C; Ladisa, N; Piano, P; Raise, E; Mussini, C; Castagna, A
Influence of gender in predicting CCR5 coreceptor usage
2008-01-01 Nozza, S; Soria, A; Visco, F; Vinci, C; Cossarini, F; Spagnuolo, V; Barda, B; Torre, L Della; Castagna, A; Lazzarin, A; Galli, L; Tambussi, G
High plasma levels of parathyroid hormone (PTH) are associated with an increased cardiovascular risk among HIV-infected subjects
2010-01-01 Spagnuolo, V; Galli, L; Salpietro, S; Vinci, C; Cossarini, F; Travi, G; Rubinacci, A; Mignogna, G; Cernuschi, M; Bossolasco, S; Lazzarin, A; Castagna, A
Effect of alpha-fetoprotein on survival in HIV-infected patients with hepatocellular carcinoma
2019-01-01 Messina, E; Galli, L; Morsica, G; Hasson, H; Bagaglio, S; Salpietro, S; Bhoori, S; Mazzaferro, V; Lazzarin, A; Castagna, A; Foppa, Cu
Long term response to mandatory anti-HBV vaccination: risks for disease acquisition and opportunities for re-vaccination within the ICONA cohort
2019-01-01 Rossotti, R.; Saracino, A.; Lorenzini, P.; Alcantarini, C.; Latini, A.; Lapadula, G.; Nozza, S.; Sarmati, L.; Girardi, E.; Castagna, A.; Monforte, A. d'Arminio; Puoti, M.
HIV-DNA levels, HLA-B*27 and HLA-DRB1*13 among LTNPs, ECs and HIV controllers
2019-01-01 Gabrieli, A.; Galli, L.; Tarkowski, M.; De Giuli, C.; Saracino, A.; Marchetti, G.; Bonora, S.; Lattuada, E.; Mena, M.; Monforte, A. D'Arminio; Castagna, A.; Riva, A.; Rusconi, S.
Evaluation of total HIV-DNA changes in HIV-1 infected patients who continue a 2-drug regimen with dolutegravir plus one reverse transcriptase inhibitor or switch to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide enrolled in the Be-One Study
2019-01-01 Santoro, M. M.; Gianotti, N.; Galli, L.; Scutari, R.; Alteri, C.; Poli, A.; Piermatteo, L.; Bigoloni, A.; Perno, C. F.; Lazzarin, A.; Ceccherini-Silberstein, F.; Castagna, A.
Impact of multi-drug resistance on mortality: a multi-cohort Italian study
2020-01-01 Gagliardini, R.; Cozzi-Lepri, A.; Zazzi, M.; Tavelli, A.; Santoro, M.; Armenia, D.; Castagna, A.; Gennari, W.; Rusconi, S.; Mussini, C.; Laghetti, P.; Perno, C.; Monforte, A. D'Arminio; Antinori, A.
Thallium-201 SPECT accuracy to detect brain lymphomas in AIDS patients using different uptake indexes
1996-01-01 Messa, C; Damico, A; Castagna, A; Zito, F; Lazzarin, A; Lucignani, G; Fazio, F
RPV plus DRV/cobi as 2DR option in HIV-infected subjects on virologic suppression
2019-01-01 Maggiolo, F.; Comi, L.; Di Filippo, E.; Fumagalli, L.; Gianotti, N.; Nozza, S.; Valenti, D.; Castagna, A.
Molecular and functional analysis of the promoter region of CFTR gene in CF and CFTR related disorders patients
2013-01-01 S., Giordano; Amato, Felice; A., Elce; M., Scorza; M., Seia; A., Angioni; F., Zarrilli; G., Castaldo; Tomaiuolo, Rossella
Evaluation of butyrate efficacy in treatment of congenital chloride diarrhea: from genotype to clinical response
2013-01-01 A., Elce; M., Scorza; Amato, Felice; G., Terrin; BERNI CANANI, Roberto; Tomaiuolo, Rossella
Gene methylation: a novel regulatory mechanism of CFTR expression
2013-01-01 Scorza, M.; Elce, A.; Giordano, S.; Tomaiuolo, Rossella
Start Up: Research And Development In Life Science
2016-01-01 Cariati, Federica; D'Argenio, Valeria; DI PAOLA, Nadia; Vona, Roberto; Tomaiuolo, Rossella
DRUG RETENTION RATES OF BIOLOGICAL AGENTS IN ADULT ONSET STILL'S DISEASE IN THE PRE-CANAKINUMAB ERA
2020-01-01 Farina, N; Tomelleri, A; Campochiaro, C; De Luca, G; Cavalli, G; Baldissera, E; Dagna, L
DAY-14 LAIP ON BONE MARROW PREDICTS COMPLETE RESPONSE AND DRIVE EARLY SALVAGE CHEMOTHERAPY IN AML: RESULTS OF MULTIPARAMETER FLOW CYTOMETRY AND WT1-RNA QUANTIFICATION
2015-01-01 Messina, C; Carrabba, Mg; Sala, E; Ronchi, P; Tresoldi, C; Tassara, M; Pavesi, F; Gentner, B; Vago, L; Ciceri, F; Milani, R; Bernardi, M
Long-term immunological profile of patients treated with haploidentical HSCT and TK-cells to unravel the requirements of memory T cell persistence
2015-01-01 Oliveira, G; Stanghellini, Mtl; Cieri, N; D'Agostino, M; Ruggiero, E; Greco, R; Mastaglio, S; Noviello, M; Vago, L; Biasco, L; Bondanza, A; Aiuti, A; Lambiase, A; Schmidt, M; Traversari, C; Von Kalle, C; Ciceri, F; Bordignon, C; Bonini, C
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Week 48 safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced participants (BRIGHTE study) | 1-gen-2018 | Aberg, J; Molina, J; Kozal, M; Cahn, P; Lalezari, J; Thompson, M; Diaz, R; Castagna, A; Pialoux, G; Gummel, M; Pierce, A; Ackerman, P; Llamoso, C; Lataillade, M | |
| THE EFFECT OF HIV-1 IN DECREASING MITOCHONDRIAL DNA IN PERIPHERAL BLOOD MONONUCLEAR CELLS OVERCOMES THE TOXIC EFFECT OF ANTIRETROVIRAL THERAPY (ART) | 1-gen-2009 | Bossolasco, S; Danise, A; Galli, L; Bestetti, A; Galli, A; Lazzarin, A; Castagna, A; Cinque, P | |
| FAILURE TO DARUNAVIR/RITONAVIR CAN EITHER INCREASE OR DECREASE TIPRANAVIR/RITONAVIR GENOTYPIC RESISTANCE SCORE IN HIGHLY TREATMENT-EXPERIENCED HIV-INFECTED PATIENTS | 1-gen-2009 | Gianotti, N; Spagnuolo, V; Bigoloni, A; Vinci, C; Salpietro, S; Seminari, E; Lazzarin, A; Castagna, A | |
| A RELATIVELY SLOW RISK OF DISEASE PROGRESSION IN HIV-POSITIVE PATIENTS WITH INDOLENT INFECTION HAS BEEN FOUND IN THE ICONA COHORT | 1-gen-2009 | Ammassari, A; Cozzi-Lepri, A; De Luca, A; Girardi, E; Arlotti, M; Torti, C; Ladisa, N; Piano, P; Raise, E; Mussini, C; Castagna, A | |
| Influence of gender in predicting CCR5 coreceptor usage | 1-gen-2008 | Nozza, S; Soria, A; Visco, F; Vinci, C; Cossarini, F; Spagnuolo, V; Barda, B; Torre, L Della; Castagna, A; Lazzarin, A; Galli, L; Tambussi, G | |
| High plasma levels of parathyroid hormone (PTH) are associated with an increased cardiovascular risk among HIV-infected subjects | 1-gen-2010 | Spagnuolo, V; Galli, L; Salpietro, S; Vinci, C; Cossarini, F; Travi, G; Rubinacci, A; Mignogna, G; Cernuschi, M; Bossolasco, S; Lazzarin, A; Castagna, A | |
| Effect of alpha-fetoprotein on survival in HIV-infected patients with hepatocellular carcinoma | 1-gen-2019 | Messina, E; Galli, L; Morsica, G; Hasson, H; Bagaglio, S; Salpietro, S; Bhoori, S; Mazzaferro, V; Lazzarin, A; Castagna, A; Foppa, Cu | |
| Long term response to mandatory anti-HBV vaccination: risks for disease acquisition and opportunities for re-vaccination within the ICONA cohort | 1-gen-2019 | Rossotti, R.; Saracino, A.; Lorenzini, P.; Alcantarini, C.; Latini, A.; Lapadula, G.; Nozza, S.; Sarmati, L.; Girardi, E.; Castagna, A.; Monforte, A. d'Arminio; Puoti, M. | |
| HIV-DNA levels, HLA-B*27 and HLA-DRB1*13 among LTNPs, ECs and HIV controllers | 1-gen-2019 | Gabrieli, A.; Galli, L.; Tarkowski, M.; De Giuli, C.; Saracino, A.; Marchetti, G.; Bonora, S.; Lattuada, E.; Mena, M.; Monforte, A. D'Arminio; Castagna, A.; Riva, A.; Rusconi, S. | |
| Evaluation of total HIV-DNA changes in HIV-1 infected patients who continue a 2-drug regimen with dolutegravir plus one reverse transcriptase inhibitor or switch to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide enrolled in the Be-One Study | 1-gen-2019 | Santoro, M. M.; Gianotti, N.; Galli, L.; Scutari, R.; Alteri, C.; Poli, A.; Piermatteo, L.; Bigoloni, A.; Perno, C. F.; Lazzarin, A.; Ceccherini-Silberstein, F.; Castagna, A. | |
| Impact of multi-drug resistance on mortality: a multi-cohort Italian study | 1-gen-2020 | Gagliardini, R.; Cozzi-Lepri, A.; Zazzi, M.; Tavelli, A.; Santoro, M.; Armenia, D.; Castagna, A.; Gennari, W.; Rusconi, S.; Mussini, C.; Laghetti, P.; Perno, C.; Monforte, A. D'Arminio; Antinori, A. | |
| Thallium-201 SPECT accuracy to detect brain lymphomas in AIDS patients using different uptake indexes | 1-gen-1996 | Messa, C; Damico, A; Castagna, A; Zito, F; Lazzarin, A; Lucignani, G; Fazio, F | |
| RPV plus DRV/cobi as 2DR option in HIV-infected subjects on virologic suppression | 1-gen-2019 | Maggiolo, F.; Comi, L.; Di Filippo, E.; Fumagalli, L.; Gianotti, N.; Nozza, S.; Valenti, D.; Castagna, A. | |
| Molecular and functional analysis of the promoter region of CFTR gene in CF and CFTR related disorders patients | 1-gen-2013 | S., Giordano; Amato, Felice; A., Elce; M., Scorza; M., Seia; A., Angioni; F., Zarrilli; G., Castaldo; Tomaiuolo, Rossella | |
| Evaluation of butyrate efficacy in treatment of congenital chloride diarrhea: from genotype to clinical response | 1-gen-2013 | A., Elce; M., Scorza; Amato, Felice; G., Terrin; BERNI CANANI, Roberto; Tomaiuolo, Rossella | |
| Gene methylation: a novel regulatory mechanism of CFTR expression | 1-gen-2013 | Scorza, M.; Elce, A.; Giordano, S.; Tomaiuolo, Rossella | |
| Start Up: Research And Development In Life Science | 1-gen-2016 | Cariati, Federica; D'Argenio, Valeria; DI PAOLA, Nadia; Vona, Roberto; Tomaiuolo, Rossella | |
| DRUG RETENTION RATES OF BIOLOGICAL AGENTS IN ADULT ONSET STILL'S DISEASE IN THE PRE-CANAKINUMAB ERA | 1-gen-2020 | Farina, N; Tomelleri, A; Campochiaro, C; De Luca, G; Cavalli, G; Baldissera, E; Dagna, L | |
| DAY-14 LAIP ON BONE MARROW PREDICTS COMPLETE RESPONSE AND DRIVE EARLY SALVAGE CHEMOTHERAPY IN AML: RESULTS OF MULTIPARAMETER FLOW CYTOMETRY AND WT1-RNA QUANTIFICATION | 1-gen-2015 | Messina, C; Carrabba, Mg; Sala, E; Ronchi, P; Tresoldi, C; Tassara, M; Pavesi, F; Gentner, B; Vago, L; Ciceri, F; Milani, R; Bernardi, M | |
| Long-term immunological profile of patients treated with haploidentical HSCT and TK-cells to unravel the requirements of memory T cell persistence | 1-gen-2015 | Oliveira, G; Stanghellini, Mtl; Cieri, N; D'Agostino, M; Ruggiero, E; Greco, R; Mastaglio, S; Noviello, M; Vago, L; Biasco, L; Bondanza, A; Aiuti, A; Lambiase, A; Schmidt, M; Traversari, C; Von Kalle, C; Ciceri, F; Bordignon, C; Bonini, C |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista3192
Data di pubblicazione
- In corso di stampa1
- 2020 - 202596
- 2010 - 20191464
- 2000 - 20091294
- 1990 - 1999321
- 1983 - 198916
Editore
- ELSEVIER22
- LIPPINCOTT WILLIAMS & WILKINS14
- NLM (Medline)13
- URBAN & VOGEL12
- ELSEVIER SCIENCE BV11
- DR DIETRICH STEINKOPFF VERLAG10
- ELSEVIER SCIENCE INC10
- OXFORD UNIV PRESS10
- SPRINGER HEIDELBERG10
- SPRINGER9
Rivista
- EUROPEAN UROLOGY. SUPPLEMENTS174
- JOURNAL OF NEUROLOGY153
- THE JOURNAL OF UROLOGY152
- BONE MARROW TRANSPLANTATION127
- EUROPEAN NEUROPSYCHOPHARMACOLOGY126
- NEUROLOGICAL SCIENCES88
- BLOOD86
- EUROPEAN HEART JOURNAL72
- NEUROLOGY72
- GASTROENTEROLOGY71
Keyword
- systemic sclerosis12
- Children4
- fibrosis4
- JIA4
- JSLE4
- None4
- angiogenesis3
- animal model3
- Bone mass3
- IPMN3
Lingua
- eng1301
- ita202
- und13
Accesso al fulltext
- no fulltext3161
- reserved25
- open6